Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers in Neurodegenerative Diseases

NCT04055532 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT04055532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04055532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers in Neurodegenerative Diseases
Lead sponsor
University of Minnesota
Phase
Observational
Overall status
Withdrawn
Start date
October 1, 2019
Completion date
October 1, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease (ad), amyotrophic lateral sclerosis (als), dementia with lewy bodies (dlb), frontotemporal lobar degeneration (ftld), hiv associated neurocognitive disorder (hand), mild cognitive impairment (mci), parkinsons disease with dementia (pdd), primary lateral sclerosis (pls), spinocerebellar ataxias (sca), temporal lobe epilepsy (tle), transient epileptic amnesia (tea)